New insights into the role of sphingosine 1-phosphate and lysophosphatidic acid in the regulation of skeletal muscle cell biology
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids - Tập 1831 - Trang 176-184 - 2013
Tài liệu tham khảo
Geeves, 1999, Structural mechanism of muscle contraction, Annu. Rev. Biochem., 68, 687, 10.1146/annurev.biochem.68.1.687
Schiaffino, 2011, Fiber types in mammalian skeletal muscles, Physiol. Rev., 91, 1447, 10.1152/physrev.00031.2010
Janssen, 2000, Skeletal muscle mass and distribution in 468 men and women aged 18–88 yr, J. Appl. Physiol., 89, 81, 10.1152/jappl.2000.89.1.81
Schiaffino, 2007, Activity-dependent signaling pathways controlling muscle diversity and plasticity, Physiology (Bethesda), 22, 269, 10.1152/physiol.00009.2007
Chopard, 2009, Molecular events and signalling pathways involved in skeletal muscle disuse-induced atrophy and the impact of countermeasures, J. Cell. Mol. Med., 13, 3032, 10.1111/j.1582-4934.2009.00864.x
Narici, 2011, Disuse of the musculo-skeletal system in space and on earth, Eur. J. Appl. Physiol., 111, 403, 10.1007/s00421-010-1556-x
Polge, 2011, Muscle actin is polyubiquitinylated in vitro and in vivo and targeted for breakdown by the E3 ligase MuRF1, FASEB J., 25, 3790, 10.1096/fj.11-180968
J.S. Karliner, Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress, Biochim. Biophys. Acta (in press) http://dx.doi.org/10.1016/j.bbalip.2012.06.006.
Karliner, 2002, Lysophospholipids and the cardiovascular system, Biochim. Biophys. Acta, 1582, 216, 10.1016/S1388-1981(02)00174-9
Owens, 2004, Molecular regulation of vascular smooth muscle cell differentiation in development and disease, Physiol. Rev., 84, 767, 10.1152/physrev.00041.2003
Tidball, 2005, Inflammatory processes in muscle injury and repair, Am. J. Physiol. Regul. Integr. Comp. Physiol., 288, R345, 10.1152/ajpregu.00454.2004
Carosio, 2011, Impact of ageing on muscle cell regeneration, Ageing Res. Rev., 10, 35, 10.1016/j.arr.2009.08.001
Carlson, 2009, Molecular aging and rejuvenation of human muscle stem cells, EMBO Mol. Med., 1, 381, 10.1002/emmm.200900045
Matsumura, 1993, Deficiency of dystrophin-associated proteins: a common mechanism leading to muscle cell necrosis in severe childhood muscular dystrophies, Neuromuscul. Disord., 3, 109, 10.1016/0960-8966(93)90002-2
Tedesco, 2010, Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells, J. Clin. Invest., 120, 11, 10.1172/JCI40373
Cossu, 2007, New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials, Trends Mol. Med., 13, 520, 10.1016/j.molmed.2007.10.003
Maceyka, 2012, Sphingosine-1-phosphate signaling and its role in disease, Trends Cell Biol., 22, 50, 10.1016/j.tcb.2011.09.003
Okudaira, 2010, Biological roles of lysophosphatidic acid signaling through its production by autotaxin, Biochimie, 92, 698, 10.1016/j.biochi.2010.04.015
Kim, 2009, Export and functions of sphingosine-1-phosphate, Biochim. Biophys. Acta, 1791, 692, 10.1016/j.bbalip.2009.02.011
Kawahara, 2009, The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors, Science, 323, 524, 10.1126/science.1167449
Hait, 2009, Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate, Science, 325, 1254, 10.1126/science.1176709
Alvarez, 2010, Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2, Nature, 465, 1084, 10.1038/nature09128
Ishii, 2004, Lysophospholipid receptors: signaling and biology, Annu. Rev. Biochem., 73, 321, 10.1146/annurev.biochem.73.011303.073731
Aoki, 2008, Two pathways for lysophosphatidic acid production, Biochim. Biophys. Acta, 1781, 513, 10.1016/j.bbalip.2008.06.005
Moolenaar, 2011, Insights into autotaxin: how to produce and present a lipid mediator, Nat. Rev. Mol. Cell Biol., 12, 674, 10.1038/nrm3188
Tigyi, 2003, Molecular mechanisms of lysophosphatidic acid action, Prog. Lipid Res., 42, 498, 10.1016/S0163-7827(03)00035-3
Brindley, 2009, Phosphatidate degradation: phosphatidate phosphatases (lipins) and lipid phosphate phosphatases, Biochim. Biophys. Acta, 1791, 956, 10.1016/j.bbalip.2009.02.007
Peest, 2008, S1P-lyase independent clearance of extracellular sphingosine 1-phosphate after dephosphorylation and cellular uptake, J. Cell. Biochem., 104, 756, 10.1002/jcb.21665
Lee, 2006, GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5, J. Biol. Chem., 281, 23589, 10.1074/jbc.M603670200
Pasternack, 2008, G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth, Nat. Genet., 40, 329, 10.1038/ng.84
Murakami, 2008, Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor, Biochem. Biophys. Res. Commun., 371, 707, 10.1016/j.bbrc.2008.04.145
Tabata, 2007, The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor, Biochem. Biophys. Res. Commun., 363, 861, 10.1016/j.bbrc.2007.09.063
Lebman, 2008, Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling, J. Lipid Res., 49, 1388, 10.1194/jlr.R800008-JLR200
Watterson, 2007, Regulation of fibroblast functions by lysophospholipid mediators: potential roles in wound healing, Wound Repair Regen., 15, 607, 10.1111/j.1524-475X.2007.00292.x
Bruni, 2008, Pleiotropic effects of sphingolipids in skeletal muscle, Cell. Mol. Life Sci., 65, 3725, 10.1007/s00018-008-8236-6
Nikolova-Karakashian, 2011, Sphingolipid metabolism, oxidant signaling, and contractile function of skeletal muscle, Antioxid. Redox Signal., 15, 2501, 10.1089/ars.2011.3940
Pebay, 2007, Stem cell regulation by lysophospholipids, Prostaglandins Other Lipid Mediat., 84, 83, 10.1016/j.prostaglandins.2007.08.004
Sampaolesi, 2003, Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts, Science, 301, 487, 10.1126/science.1082254
Donati, 2007, Sphingosine 1-phosphate mediates proliferation and survival of mesoangioblasts, Stem Cells, 25, 1713, 10.1634/stemcells.2006-0725
Donati, 2009, TGFbeta protects mesoangioblasts from apoptosis via sphingosine kinase-1 regulation, Cell. Signal., 21, 228, 10.1016/j.cellsig.2008.10.007
Donati, 2011, Sphingosine 1-phosphate induces differentiation of mesoangioblasts towards smooth muscle. A role for GATA6, PLoS One, 6, e20389, 10.1371/journal.pone.0020389
Nincheri, 2009, Sphingosine 1-phosphate induces differentiation of adipose tissue-derived mesenchymal stem cells towards smooth muscle cells, Cell. Mol. Life Sci., 66, 1741, 10.1007/s00018-009-9181-8
Jeon, 2008, Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells, Stem Cells, 26, 789, 10.1634/stemcells.2007-0742
Jeon, 2010, Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells, Exp. Mol. Med., 42, 280, 10.3858/emm.2010.42.4.027
Sampaolesi, 2006, Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs, Nature, 444, 574, 10.1038/nature05282
Weinreb, 2006, Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity, Prostaglandins Leukot. Essent. Fatty Acids, 75, 81, 10.1016/j.plefa.2006.06.004
Annabi, 2003, Matrix metalloproteinase regulation of sphingosine-1-phosphate-induced angiogenic properties of bone marrow stromal cells, Exp. Hematol., 31, 640, 10.1016/S0301-472X(03)00090-0
Meriane, 2006, Stem Cells, 24, 2557, 10.1634/stemcells.2006-0209
Mansell, 2011, Lysophosphatidic acid and calcitriol co-operate to promote human osteoblastogenesis: requirement of albumin-bound LPA, Prostaglandins Other Lipid Mediat., 95, 45, 10.1016/j.prostaglandins.2011.05.003
Nagata, 2006, Entry of muscle satellite cells into the cell cycle requires sphingolipid signaling, J. Cell Biol., 174, 245, 10.1083/jcb.200605028
Calise, 2012, Sphingosine 1-phosphate stimulates proliferation and migration of satellite cells: role of S1P receptors, Biochim. Biophys. Acta, 1823, 439, 10.1016/j.bbamcr.2011.11.016
Matsuyuki, 2006, Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P, Cell. Mol. Immunol., 3, 429
Yaffe, 1977, Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle, Nature, 270, 725, 10.1038/270725a0
Yoshida, 1998, Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates ‘reserve cells’, J. Cell Sci., 111, 769, 10.1242/jcs.111.6.769
Yoshida, 1996, Lysophosphatidic acid and bFGF control different modes in proliferating myoblasts, J. Cell Biol., 132, 181, 10.1083/jcb.132.1.181
Jean-Baptiste, 2005, Lysophosphatidic acid mediates pleiotropic responses in skeletal muscle cells, Biochem. Biophys. Res. Commun., 335, 1155, 10.1016/j.bbrc.2005.08.011
Xu, 2008, Mechanisms of the lysophosphatidic acid-induced increase in [Ca(2+)](i) in skeletal muscle cells, J. Cell. Mol. Med., 12, 942, 10.1111/j.1582-4934.2008.00139.x
Meacci, 1999, Receptor-mediated activation of phospholipase D by sphingosine 1-phosphate in skeletal muscle C2C12 cells. A role for protein kinase C, FEBS Lett., 457, 184, 10.1016/S0014-5793(99)01033-9
Meacci, 2000, Permissive role of protein kinase C alpha but not protein kinase C delta in sphingosine 1-phosphate-induced Rho A activation in C2C12 myoblasts, FEBS Lett., 482, 97, 10.1016/S0014-5793(00)02039-1
Meacci, 2002, Sphingosine 1-phosphate evokes calcium signals in C2C12 myoblasts via Edg3 and Edg5 receptors, Biochem. J., 362, 349, 10.1042/0264-6021:3620349
Meacci, 2003
Donati, 2005, Sphingosine 1-phosphate regulates myogenic differentiation: a major role for S1P2 receptor, FASEB J., 19, 449, 10.1096/fj.04-1780fje
Kwon, 2007, Novel synthetic ceramide derivatives increase intracellular calcium levels and promote epidermal keratinocyte differentiation, J. Lipid Res., 48, 1936, 10.1194/jlr.M700185-JLR200
Bernacchioni, 2011, The sphingosine kinase activator K6PC-5 stimulates C2C12 myoblast differentiation, Int. J. Immunopathol. Pharmacol., 24, 55, 10.1177/039463201102400107
Rapizzi, 2008, Sphingosine 1-phosphate differentially regulates proliferation of C2C12 reserve cells and myoblasts, Mol. Cell. Biochem., 314, 193, 10.1007/s11010-008-9780-y
Formigli, 2007, Cytoskeleton/stretch-activated ion channel interaction regulates myogenic differentiation of skeletal myoblasts, J. Cell. Physiol., 211, 296, 10.1002/jcp.20936
Meacci, 2010, Functional interaction between TRPC1 channel and connexin-43 protein: a novel pathway underlying S1P action on skeletal myogenesis, Cell. Mol. Life Sci., 67, 4269, 10.1007/s00018-010-0442-3
Meacci, 2008, Sphingosine kinase activity is required for myogenic differentiation of C2C12 myoblasts, J. Cell. Physiol., 214, 210, 10.1002/jcp.21187
E. Germinario, S. Peron, L. Toniolo, R. Betto, F. Cencetti, C. Donati, P. Bruni, D. Danieli-Betto. S1P2 receptor promotes mouse skeletal muscle regeneration, J. Appl. Physiol http//dx.doi.org/10.1152/japplphysiol.00300.2012.
Becciolini, 2006, Sphingosine 1-phosphate inhibits cell migration in C2C12 myoblasts, Biochim. Biophys. Acta, 1761, 43, 10.1016/j.bbalip.2006.01.006
Suzuki, 2000, Involvement of Ras and Ral in chemotactic migration of skeletal myoblasts, Mol. Cell. Biol., 20, 4658, 10.1128/MCB.20.13.4658-4665.2000
Lepley, 2005, The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration, Cancer Res., 65, 3788, 10.1158/0008-5472.CAN-04-2311
Zanin, 2008, Trophic action of sphingosine 1-phosphate in denervated rat soleus muscle, Am. J. Physiol. Cell Physiol., 294, C36, 10.1152/ajpcell.00164.2007
Sassoli, 2011, Effects of S1P on skeletal muscle repair/regeneration during eccentric contraction, J. Cell. Mol. Med., 15, 2498, 10.1111/j.1582-4934.2010.01250.x
Li, 2001, TNF-alpha regulates early differentiation of C2C12 myoblasts in an autocrine fashion, FASEB J., 15, 1413, 10.1096/fj.00-0632fje
Donati, 2007, Tumor necrosis factor-alpha exerts pro-myogenic action in C2C12 myoblasts via sphingosine kinase/S1P2 signaling, FEBS Lett., 581, 4384, 10.1016/j.febslet.2007.08.007
Bernacchioni, 2012, Sphingosine kinase/sphingosine 1‐phosphate axis: a new player for insulin like growth factor-1-induced myoblast differentiation, Skelet. Muscle, 2, 15, 10.1186/2044-5040-2-15
Yablonka-Reuveni, 1990, Regulation of proliferation and differentiation of myoblasts derived from adult mouse skeletal muscle by specific isoforms of PDGF, J. Cell Biol., 111, 1623, 10.1083/jcb.111.4.1623
Nincheri, 2010, Sphingosine kinase-1/S1P1 signalling axis negatively regulates mitogenic response elicited by PDGF in mouse myoblasts, Cell. Signal., 22, 1688, 10.1016/j.cellsig.2010.06.009
Mann, 2011, Aberrant repair and fibrosis development in skeletal muscle, Skeleton Muscle, 1, 21, 10.1186/2044-5040-1-21
Burks, 2011, Role of TGF-beta signaling in inherited and acquired myopathies, Skeleton Muscle, 1, 19, 10.1186/2044-5040-1-19
Cohn, 2007, Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states, Nat. Med., 13, 204, 10.1038/nm1536
Cencetti, 2010, Transforming growth factor-beta1 induces transdifferentiation of myoblasts into myofibroblasts via up-regulation of sphingosine kinase-1/S1P3 axis, Mol. Biol. Cell, 21, 1111, 10.1091/mbc.E09-09-0812
Vial, 2008, Skeletal muscle cells express the profibrotic cytokine connective tissue growth factor (CTGF/CCN2), which induces their dedifferentiation, J. Cell. Physiol., 215, 410, 10.1002/jcp.21324
Cabello-Verrugio, 2011, Connective tissue growth factor induction by lysophosphatidic acid requires transactivation of transforming growth factor type beta receptors and the JNK pathway, Cell. Signal., 23, 449, 10.1016/j.cellsig.2010.10.019
Ma, 2007, Sphingosine kinase 1 participates in insulin signalling and regulates glucose metabolism and homeostasis in KK/Ay diabetic mice, Diabetologia, 50, 891, 10.1007/s00125-006-0589-5
Rapizzi, 2009, Sphingosine 1-phosphate increases glucose uptake through trans-activation of insulin receptor, Cell. Mol. Life Sci., 66, 3207, 10.1007/s00018-009-0106-3
Baranowski, 2011, Exercise increases plasma levels of sphingoid base-1 phosphates in humans, Acta Physiol (Oxf.), 203, 373, 10.1111/j.1748-1716.2011.02322.x
Yea, 2008, Lysophosphatidic acid regulates blood glucose by stimulating myotube and adipocyte glucose uptake, J. Mol. Med. (Berl.), 86, 211, 10.1007/s00109-007-0269-z
Hilber, 2008, Skeletal myocyte plasticity: basis for improved therapeutic potential?, Curr. Opin. Pharmacol., 8, 327, 10.1016/j.coph.2008.01.007
Westerblad, 2010, Skeletal muscle: energy metabolism, fiber types, fatigue and adaptability, Exp. Cell Res., 316, 3093, 10.1016/j.yexcr.2010.05.019
Sandri, 2008, Signaling in muscle atrophy and hypertrophy, Physiology (Bethesda), 23, 160, 10.1152/physiol.00041.2007
Minetti, 2011, Galphai2 signaling promotes skeletal muscle hypertrophy, myoblast differentiation, and muscle regeneration, Sci. Signal., 4, ra80, 10.1126/scisignal.2002038
De Larichaudy, 2012, TNFalpha- and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism, Skeleton Muscle, 2, 2, 10.1186/2044-5040-2-2
Chun, 2011, A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya), Discov. Med., 12, 213
Danieli-Betto, 2005, Sphingosine 1-phosphate protects mouse extensor digitorum longus skeletal muscle during fatigue, Am. J. Physiol. Cell Physiol., 288, C1367, 10.1152/ajpcell.00246.2004
Bencini, 2003, Effects of sphingosine 1-phosphate on excitation-contraction coupling in mammalian skeletal muscle, J. Muscle Res. Cell Motil., 24, 539, 10.1023/B:JURE.0000009898.02325.58